NRG-GU006 at the 2025 ASTRO Clinical Trials Session episode artwork

EPISODE · Sep 28, 2025 · 36 MIN

NRG-GU006 at the 2025 ASTRO Clinical Trials Session

from The NRG Oncology Podcast · host NRG Oncology

Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.

Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.

NOW PLAYING

NRG-GU006 at the 2025 ASTRO Clinical Trials Session

0:00 36:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 36 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on September 28, 2025.

What is this episode about?

Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical...

Can I download this The NRG Oncology Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!